Subject | Sex | Age | HED-related genotype | Zygosity | Ectodysplasin A | Blood | PCR test for | Duration of | IgG against | Postinfectious | |
---|---|---|---|---|---|---|---|---|---|---|---|
(m/f) | (years) | Gene | Pathogenic variant | Signalling | group | SARS-CoV-2 | COVID-19 | SARS-CoV-2 | fatigue | ||
ED-A1 | m | 49 | EDA | c.1091T > G (p.M364R) | Hemizygous | Abrogated | A Rh + | pos. (03/2020) | 22 days | Yes | Moderate |
ED-A2 | f | 27 | EDAR | c.486delC | Homozygous | Abrogated | B Rh + | n.d. (03/2020) | 8 days | Yes | Severe |
ED-A3 | m | 20 | EDA | c.896G > C (p.G299A) | Hemizygous | Abrogated | 0 Rh + | pos. (11/2020) | 13 days | Yes | None |
ED-A4 | m | 46 | EDA | del exons 4–9 | Hemizygous | Abrogated | 0 Rh + | pos. (12/2020) | 23 days | Yes | Severe |
ED-Y1 | m | 15 | EDA | c.896G > C (p.G299A) | Hemizygous | Abrogated | 0 Rh + | pos. (10/2020) | 45 days | Yes | Moderate |
ED-Y2 | m | 16 | EDA | c.477C > T (p.R153C) | Hemizygous | Abrogated | n.d | pos. (11/2020) | 12 days | Yes | Extreme |
ED-C1 | m | 9 | EDA | c.45_49del5 | Hemizygous | Abrogated | n.d | n.d. (03/2020) | no symptoms | Yes | None |
ED-A5 | f | 37 | EDA | c.466C > T (p.R156C) | heterozygous | residual activity | 0 Rh + | pos. (03/2020) | 13 days | Yes | None |
ED-A6 | f | 40 | EDA | c.45_49del5 | Heterozygous | Residual activity | 0 Rh + | n.d. (03/2020) | 27 days | Yes | None |
ED-A7 | f | 19 | EDA | c.896G > C (p.G299A) | Heterozygous | Residual activity | 0 Rh- | pos. (10/2020) | 3 days | yes | none |
ED-A8 | m | 22 | EDA | c.769G > C (p.G257R) | Hemizygous | Residual activity | 0 Rh- | pos. (10/2020) | 7 days | Yes | None |
ED-A9 | f | 42 | EDA | c.896G > C (p.G299A) | Heterozygous | Residual activity | 0 Rh- | pos. (10/2020) | 21 days | Yes | Mild |
ED-A10 | f | 46 | EDA | c.477C > T (p.R153C) | Heterozygous | Residual activity | A Rh + | pos. (11/2020) | 4 days | Yes | None |
ED-A11 | f | 52 | EDA | c.896G > C (p.G299A) | Heterozygous | Residual activity | 0 Rh + | pos. (11/2020) | 20 days | Yes | Moderate |
ED-Y3 | f | 16 | EDA | c.1091T > G (p.M364R) | Heterozygous | Residual activity | A Rh + | pos. (03/2020) | 7 days | Yes | None |